SYNCRIP and hepatocellular carcinoma: To explore the mechanism underlying NAT10's involvement in HCC tumorigenicity, we first noted that NAT10 enhances mRNA stability through its interaction with heterogeneous nuclear ribonucleoprotein Q (HNRNPQ) [30].